| dc.contributor.author | Danchin, Antoine | |
| dc.contributor.author | TURINICI, Gabriel | |
| dc.date.accessioned | 2020-06-16T19:19:30Z | |
| dc.date.available | 2020-06-16T19:19:30Z | |
| dc.date.issued | 2020-05-23 | |
| dc.identifier.uri | https://doi.org/10.1101/2020.05.21.20108860 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12663/1765 | |
| dc.description.abstract | Motivated by historical and present clinical observations, we discuss the possible unfavorable evolution of the immunity (similar to documented antibody-dependent enhancement scenarios) after a first infection with COVID-19. More precisely we ask the question of how the epidemic outcomes are affected if the initial infection does not provide immunity but rather sensitization to future challenges. We first provide background comparison with the 2003 SARS epidemic. Then we use a compartmental epidemic model structured by immunity level (taken here as age classes) that we fit on available data; this allows to derive quantitative insights into the future number of severe cases and deaths. | en_US |
| dc.language | English | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | Coronavirus | en_US |
| dc.subject | Immunity | en_US |
| dc.subject | Protection | en_US |
| dc.subject | Severe Acute Respiratory Syndrome | en_US |
| dc.subject | Death | en_US |
| dc.subject | Epidemics | en_US |
| dc.title | Immunity after COVID-19: protection or sensitization ? | en_US |
| eihealth.country | Global (WHO/OMS) | en_US |
| eihealth.category | Epidemiology and epidemiological studies | en_US |
| eihealth.type | Published Article | en_US |
| eihealth.maincategory | Slow Spread / Reducir la Dispersión | en_US |
| dc.relation.ispartofjournal | medRxiv | en_US |
